FDA expands Pfizer COVID booster, opens extra dose to age 16

On Thursday, the FDA gave emergency authorization for 16- and 17-year-olds to get a third dose of the vaccine made by Pfizer and its partner BioNTech — if it’s been six months since their last shot.